Cardlytics (CDLX) Set to Announce Earnings on Wednesday

Cardlytics (NASDAQ:CDLX) will be posting its quarterly earnings results after the market closes on Wednesday, November 6th. Analysts expect Cardlytics to post earnings of ($0.33) per share for the quarter. Cardlytics has set its Q3 2024 guidance at EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.12. The business had revenue of $69.64 million for the quarter, compared to the consensus estimate of $75.39 million. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. Cardlytics’s quarterly revenue was down 9.2% on a year-over-year basis. During the same quarter last year, the company posted ($0.57) earnings per share. On average, analysts expect Cardlytics to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Cardlytics Stock Down 3.0 %

Shares of CDLX stock opened at $4.18 on Monday. The stock has a market cap of $208.33 million, a P/E ratio of -1.09 and a beta of 1.61. Cardlytics has a one year low of $2.89 and a one year high of $20.52. The stock has a fifty day moving average price of $3.63 and a 200 day moving average price of $6.93. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.77 and a quick ratio of 1.77.

Insider Buying and Selling

In related news, CEO Amit Gupta sold 22,607 shares of Cardlytics stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $3.85, for a total value of $87,036.95. Following the completion of the sale, the chief executive officer now directly owns 178,519 shares in the company, valued at $687,298.15. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Scott A. Hill bought 40,000 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was bought at an average cost of $3.58 per share, for a total transaction of $143,200.00. Following the transaction, the director now owns 40,000 shares of the company’s stock, valued at $143,200. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Amit Gupta sold 22,607 shares of Cardlytics stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $3.85, for a total value of $87,036.95. Following the transaction, the chief executive officer now owns 178,519 shares in the company, valued at $687,298.15. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,573 shares of company stock worth $151,612 over the last three months. 4.40% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Lake Street Capital cut Cardlytics from a “buy” rating to a “hold” rating and reduced their target price for the stock from $18.00 to $5.00 in a research report on Thursday, August 8th. Craig Hallum cut Cardlytics from a “buy” rating to a “hold” rating in a report on Thursday, August 8th. Northland Securities cut Cardlytics from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $7.00 to $5.00 in a report on Friday, August 16th. Needham & Company LLC cut Cardlytics from a “buy” rating to a “hold” rating in a report on Thursday, August 8th. Finally, Evercore ISI initiated coverage on Cardlytics in a report on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective for the company. One investment analyst has rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $6.92.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.